Predictive Technology Group Inc (PRED)

[stockguru1971]

The short term issue is per fda mandate, the non fda stem cell market will be severely regulated and while pred are the standard bearers, it will have an impact on revenues. As such the fda want parties in the space to do trials which no doubt pred will do but it will have an impact short term.
The reason big biotech/pharma investors don’t like stem cell is purely because it’s unregulated and as such has huge exposure if something went wrong


The fertility business is wide open for them
And with their IP, the own the endometriosis market, that’s the future growth, especially in China where it’s a huge problem